US · Healthcare

Premier Biomedical Inc (BIEI)

Drug Manufacturers - Specialty & Generic

Premier Biomedical Inc (BIEI) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BIEI

P/E ratio

18.00

Premier Biomedical Inc (BIEI) — FAQ

What is BIEI's P/E ratio?

The price-to-earnings (P/E) ratio for Premier Biomedical Inc (BIEI) is 18.00 (data as of 2026-03-23).

Does Premier Biomedical Inc pay a dividend?

Dividend yield is not available in the current snapshot for Premier Biomedical Inc (BIEI). Check the MyAverix Finance app for the latest dividend data.

What sector is Premier Biomedical Inc in?

Premier Biomedical Inc (BIEI) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is BIEI listed on?

BIEI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)